Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bonoprazan vs Esomeprazole for NSAID-induced GI erosions and ulcers
NCT03315676Phase 2Unknown
- Sponsor
- Shinshu University
- Start
- Nov 2017
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in Peptic ulcer disease (PUD) (2 arms), sponsored by Shinshu University. Primary endpoint: Number of participants with healing of gastrointestinal erosions and/or ulcers at 2 weeks. Status: unknown.
02
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT03315676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03315676.